Roche’s Irish arm shows losses of €3m

THE Irish subsidiary of Swiss-owned pharmaceutical giant and swine flu drug producer Roche, made pre-tax losses of just over €3 million last year.

The company said the €12m reduction in profit was due to a 22% reduction in production output.

It said production and cost levels for 2010 are forecasted to be similar to 2009.